Delivery Order SPE2DB22D3401-SPE2DB26FT0RL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,093.79 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,004.48 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 microgram vaginal inserts (18-count package) on November 6, 2025, with completion expected by November 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.80 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The awardee, AmerisourceBergen Drug Corp, is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and the place of performance is also located in...
- The Defense Logistics Agency awarded a $1,467.14 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for Yuvafem 10 mcg vaginal inserts (18 count). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside designation and is scheduled for completion by October 29, 2025, with performance at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $2,144.01 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.03 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (18-count). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of November 12, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on September 15, 2025, for Yuvafem 10 mcg vaginal inserts (18-count package). This is a firm fixed-price delivery order with a ceiling value of $1,616.52, with an ultimate completion date of September 16, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,502.24 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (8-count units). This firm fixed-price, non-set-aside delivery order was awarded on August 28, 2025, with an ultimate completion date of August 29, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,209.68 to AmerisourceBergen Drug Corp for Yuvafem 10 microgram vaginal inserts (18 count) on August 21, 2025, with completion expected by August 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,568.22 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on June 18, 2025, with completion scheduled for June 20, 2025. This firm fixed-price, non-set-aside delivery order was fulfilled at the vendor's Conshohocken, Pennsylvania location. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs within DLA's supply chain operations. This delivery...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB26FT0RLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,396.56 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its DLA Troop Support Medical IDC to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. The contract vehicle enables the company to fulfill federal medical procurement needs across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for Yuvafem, a hormone treatment medication, exemplifies the company's role in providing specialized pharmaceutical commodities to support military healthcare programs through flexible and competitively awarded ordering mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/6/25 |